Atlas Trials

Efficacy and Safety Study of 5 mg and 10 mg Rosuvastatin

Clinical trial NCT01613729 · UNKNOWN

Trial details

NCT number
NCT01613729
Sponsor
D16 Pharma & Biotec Ltd.
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Dyslipidemia
Start date
2012-07-01
Primary completion
2013-07-01
Enrollment
2000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.